Yield10 Bioscience

company

About

Metabolix offers sustainable solutions for the plastics, chemicals and energy industries.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$6M
Industries
Biotechnology,Chemical,Energy
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$18.70M
Yield10 Bioscience has raised a total of $18.70M in funding over 2 rounds. Their latest funding was raised on Jan 31, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 31, 2021 Post-IPO Equity $12.70M 1 Jack W. Schuler Living Trust Detail
May 5, 2011 Grant $6M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Yield10 Bioscience is funded by 2 investors. Jack W. Schuler Living Trust and US Department of Energy are the most recent investors.
Investor Name Lead Investor Funding Round
Jack W. Schuler Living Trust Yes Post-IPO Equity
US Department of Energy Grant